| High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer S Salcher, G Sturm, L Horvath, G Untergasser, C Kuempers, G Fotakis, ... Cancer cell 40 (12), 1503-1520. e8, 2022 | 107 | 2022 |
| C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy S Salcher, M Hermann, U Kiechl-Kohlendorfer, MJ Ausserlechner, ... Molecular cancer 16, 1-17, 2017 | 90 | 2017 |
| A New Approach in Cancer Treatment: Discovery of Chlorido[N,N′-disalicylidene-1,2-phenylenediamine]iron(III) Complexes as Ferroptosis Inducers J Sagasser, BN Ma, D Baecker, S Salcher, M Hermann, J Lamprecht, ... Journal of Medicinal Chemistry 62 (17), 8053-8061, 2019 | 55 | 2019 |
| C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma S Salcher, J Hagenbuchner, K Geiger, MA Seiter, J Rainer, R Kofler, ... Molecular Cancer 13, 1-17, 2014 | 52 | 2014 |
| Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer I Heidegger, G Fotakis, A Offermann, J Goveia, S Daum, S Salcher, ... Molecular Cancer 21 (1), 132, 2022 | 50 | 2022 |
| A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma S Salcher, G Spoden, J Hagenbuchner, S Führer, T Kaserer, M Tollinger, ... Oncogene 39 (5), 1080-1097, 2020 | 35 | 2020 |
| Immune cell dynamics deconvoluted by single-cell RNA sequencing in normothermic machine perfusion of the liver T Hautz, S Salcher, M Fodor, G Sturm, S Ebner, A Mair, M Trebo, ... Nature Communications 14 (1), 2285, 2023 | 21 | 2023 |
| Repaglinide silences the FOXO3/Lumican axis and represses the associated metastatic potential of neuronal cancer cells S Salcher, G Spoden, JM Huber, G Golderer, H Lindner, ... Cells 9 (1), 1, 2019 | 16 | 2019 |
| Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulators AM Schoepf, S Salcher, P Obexer, R Gust European Journal of Medicinal Chemistry 185, 111748, 2020 | 15 | 2020 |
| Discovery of Sanggenon G as a natural cell-permeable small-molecular weight inhibitor of X-linked inhibitor of apoptosis protein (XIAP) MA Seiter, S Salcher, M Rupp, J Hagenbuchner, U Kiechl-Kohlendorfer, ... FEBS Open bio 4, 659-671, 2014 | 14 | 2014 |
| Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition F Kocher, P Tymoszuk, A Amann, S Sprung, S Salcher, S Daum, ... Lung Cancer 159, 84-95, 2021 | 12 | 2021 |
| The biology of classic hairy cell leukemia JP Bohn, S Salcher, A Pircher, G Untergasser, D Wolf International Journal of Molecular Sciences 22 (15), 7780, 2021 | 11 | 2021 |
| Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic … AM Schoepf, S Salcher, P Obexer, R Gust European Journal of Medicinal Chemistry 195, 112258, 2020 | 6 | 2020 |
| Reaction Behavior of [1,3-Diethyl-4,5-diphenyl-1H-imidazol-2-ylidene] Containing Gold(I/III) Complexes against Ingredients of the Cell Culture Medium and the … P Kapitza, A Scherfler, S Salcher, S Sopper, M Cziferszky, K Wurst, R Gust Journal of Medicinal Chemistry 66 (12), 8238-8250, 2023 | 5 | 2023 |
| The liver-resident immune cell repertoire-A boon or a bane during machine perfusion? M Fodor, S Salcher, H Gottschling, A Mair, M Blumer, S Sopper, S Ebner, ... Frontiers in Immunology 13, 982018, 2022 | 5 | 2022 |
| Changes in systemic levels of vascular endothelial growth factor after intravitreal injection of aflibercept or brolucizumab for neovascular age-related macular degeneration R Angermann, AL Huber, Y Nowosielski, S Salcher, T Gasser, C Seifarth, ... Retina 42 (3), 503-510, 2022 | 5 | 2022 |
| Synthesis and characterization of Telmisartan‐derived cell death modulators to circumvent imatinib resistance in chronic myeloid leukemia AM Schoepf, S Salcher, V Hohn, F Veider, P Obexer, R Gust ChemMedChem 15 (12), 1067-1077, 2020 | 5 | 2020 |
| Characterization of the XIAP-inhibiting proanthocyanidin fraction of the aerial parts of Ephedra sinica S Schäfer, S Salcher, M Seiter, C Ranninger, M Möst, P Obexer, ... Planta Medica 82 (11/12), 973-985, 2016 | 4 | 2016 |
| Tackling resistance in chronic myeloid leukemia: Novel cell death modulators with improved efficacy AM Schoepf, S Salcher, P Obexer, R Gust European Journal of Medicinal Chemistry 216, 113285, 2021 | 3 | 2021 |
| Comparative Analysis of Whole Transcriptome Single-Cell Sequencing Technologies in Complex Tissues S Salcher, I Heidegger, G Untergasser, G Fotakis, A Scheiber, ... bioRxiv, 2023.07. 03.547464, 2023 | 1 | 2023 |
